Dana Longstreth, SLP in Eureka, MT - Speech-Language Pathologist

Dana Longstreth, SLP is a Speech-language Pathologist based in Eureka, Montana. Dana Longstreth is licensed to practice in Montana (license number 3459) and her current practice location is 298 Osloski Rd, Eureka, Montana. She can be reached at her office (for appointments etc.) via phone at (406) 297-3915.

NPI number for Dana Longstreth is 1316364557 and her current mailing address is 298 Osloski Rd, Eureka, Montana. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1316364557.

Contact Information

	Dana Longstreth, SLP
	298 Osloski Rd, Eureka, MT 59917-9058
	(406) 297-3915
	(406) 297-3919

Healthcare Provider's Profile

Full Name	Dana Longstreth
Gender	Female
Speciality	Speech-language Pathologist
Location	298 Osloski Rd, Eureka, Montana
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1316364557
Provider Enumeration Date: 03/26/2014
Last Update Date: 03/26/2014

Medical Identifiers

Medical identifiers for Dana Longstreth such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1316364557	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	3459 (Montana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dana Longstreth is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dana Longstreth, SLP 298 Osloski Rd, Eureka, MT 59917-9058 Ph: (406) 297-3915	Dana Longstreth, SLP 298 Osloski Rd, Eureka, MT 59917-9058 Ph: (406) 297-3915

News Archive

Aditlys develops bioresorbable vascular access solution for hemodialysis patients

Aditlys is the first medical technology firm to develop a bioresorbable vascular access solution for patients undergoing dialysis treatment for chronic kidney disease. Aditlys' polymer-based graft enables a patient's body to naturally reconstruct its own blood vessels using the body's own tissue.

Lomitapide shows promise in treating homozygous familial hypercholesterolemia

An international effort led by researchers at the Perelman School of Medicine at the University of Pennsylvania has resulted in positive phase 3 clinical trial results for a new medicine to treat patients suffering from a rare and deadly cholesterol disorder.

Epicure project: an interview with Frédéric Cren

Epicure is a project led by Inventiva and Institut Curie that aims to deliver pre-clinical candidates on two novel epigenetic targets that have been selected due to their potential to activate immune responses against cancer cells. In addition one of these two targets has potential in respiratory indications such as asthma or COPD.

DLKI-DIO3 miRNA cluster suppresses spread of cancer from its primary site

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have uncovered a group of what have been considered relatively minor regulators in the body that band together to suppress the spread of cancer from its primary site.

Speech-Language Pathologist in Eureka, MT

Rachelle Elaine Mccully, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10 Mountain View Dr, Eureka, MT 59917 Phone: 406-297-2541
Melinda Diane Heinz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 250 Pings Rd, Eureka, MT 59917 Phone: 406-889-3570

Dana Longstreth, SLP - Speech-Language Pathologist in Eureka, MT